A randomized, double-blind, placebo-controlled, cross-over trial to evaluate the effect of EstroSense ® on 2-hydroxyestrone:16α-hydroxyestrone ratio in premenopausal women.

Journal of Complementary and Integrative Medicine（2023）

引用 1|浏览5

暂无评分

摘要

http://clinicaltrials.gov (NCT02385916).

查看译文

关键词

2-hydroxyestrone:16α-hydroxyestrone ratio,EstroSense,breast cancer,cancer biomarkers,natural health products,urinary estrogens

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要